Effects of methylprednisolone on pulmonary microcirculation.
D000818:Animals; D001285:Atropine / Q000494:pharmacology / Q000627:therapeutic use; D002196:Capillaries / Q000503:physiopathology; D004285:Dogs; D005260:Female; D005665:Furosemide / Q000494:pharmacology / Q000627:therapeutic use; D006470:Hemorrhage / Q000150:complications; D007022:Hypotension / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D008168:Lung / Q000098:blood supply* / Q000473:pathology; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology* / Q000627:therapeutic use; D008833:Microcirculation / Q000187:drug effects*; D011650:Pulmonary Alveoli / Q000098:blood supply; D011651:Pulmonary Artery / Q000503:physiopathology; D001261:Pulmonary Atelectasis / Q000209:etiology / Q000473:pathology; D011652:Pulmonary Circulation / Q000187:drug effects*; D011665:Pulmonary Valve Insufficiency / Q000209:etiology; D011667:Pulmonary Veins / Q000503:physiopathology; D014690:Venous Pressure / Q000187:drug effects
D001285:Atropine; D005665:Furosemide; D008775:Methylprednisolone